With advances in cancer treatment, more pediatric cancer patients have increased their life expectancy.
Because cancer-related therapy causes various physical and psychological problems, many male survivors experience later problems with thyroid and sexual functions, and with growth. As outcomes have improved, more survivors need to maintain their reproductive function to maximize their long-term quality of life. Cancer and cancer-related treatment can impair fertility by damage to the testes, to the hypothalamic-pituitary-gonadal axis, or to the genitourinary organs. Prior radiation therapy to the testes, the use of alkylating agents, and central hypogonadism further impair fertility in male survivors of childhood cancer. Following any course of chemotherapy, peripubertal maturation, any testicular volume changes, and symptoms of androgen deficiency should be monitored systematically. If patients request fertility testing, spermatogenesis status can be evaluated either directly by semen analysis or indirectly by determination of the levels of testosterone/gonadotropins and by monitoring any changes in testicular volume. According to the patient's condition, semen cryopreservation, hormonal therapy, or assisted reproduction technologies should be provided.
Written by:
Lee SH, Shin CH. Are you the author?
Department of Pediatrics, Gachon University Gil Medical Center, Incheon, Korea; Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea.
Reference: Ann Pediatr Endocrinol Metab. 2013 Dec;18(4):168-172.
doi: 10.6065/apem.2013.18.4.168
PubMed Abstract
PMID: 24904872
UroToday.com Male Infertility & Reproduction Section
